If you’ve recently suffered a heart attack, continuous glucose monitoring (CGM) can help you take control of your recovery. In this guide, Dr. Philip Ovadia explains how tracking your blood sugar supports better metabolic health, reduces inflammation, and lowers the risk of a second heart attack. Learn how to interpret your CGM data, identify your unique glucotype, and pair real-time glucose tracking with blood work to optimize long-term heart health.
Most people track blood sugar and blood pressure to assess metabolic health — but your resting heart rate (RHR) may be the missing piece. A high RHR can signal metabolic dysfunction even in those who appear fit or have normal labs. In this article, Dr. Philip Ovadia explains why RHR is such a powerful indicator, how to measure it at home in 30 seconds, and practical ways to lower it through better sleep, stress management, and exercise.
Most doctors never mention nutrient density—yet it’s one of the strongest defenses against heart disease. In this article, Dr. Philip Ovadia explains what nutrient-dense eating really means, why bioavailability matters, and how to build a diet that truly supports cardiovascular and metabolic health.
Artificial fats like EPG may promise fewer calories, but the risks outweigh the benefits. From robbing your body of vital fat-soluble vitamins to hiding in ultra-processed foods, EPG could harm metabolic health and long-term nutrition. Learn why whole, real food — including healthy fats — remains the superior choice for gut, heart, and overall wellness.
Discover how ketogenic diets change key biomarkers like insulin, CRP, cholesterol, testosterone, and cortisol—what to expect and why it matters.
Most people think high LDL cholesterol automatically means high heart disease risk. But research shows it’s not just about cholesterol levels—it’s about particle size. Small, dense LDL particles are far more dangerous than large, buoyant ones, and they’re strongly tied to insulin resistance, diabetes, and metabolic syndrome. This guide explains why LDL particle size matters, how to measure it, and proven ways to reduce small LDL through diet, fasting, and lifestyle changes.
Emerging research reveals a strong link between cardiac amyloidosis and insulin resistance. Once considered rare, cardiac amyloidosis is now increasingly recognized as a metabolic condition tied to poor glucose control and chronic inflammation. Learn how insulin resistance contributes to this underdiagnosed form of heart disease—and what you can do to reverse it through diet, movement, and lifestyle changes.
A heart surgeon breaks down misleading metabolic health advice trending on social media—from GLP-1 weight loss drugs to outdated diabetes studies and plant-based diets for kids. Learn what the research really says and how to make smarter health choices.
Some doctors call it a miracle drug. Others, the answer to America’s obesity epidemic. I call it an unknown quantity — because GLP-1 medications like Ozempic have many more long term consequences than are currently being discussed. In the same way statins haven’t cured heart disease and SSRIs don’t solve depression, GLP-1 agonists aren’t necessarily
Most people who suffer heart attacks never saw it coming—because traditional risk factors like cholesterol and family history often miss the mark. In this article, Dr. Philip Ovadia reveals three of the most accurate tests for assessing heart disease risk today, including CAC scans, hs-CRP, and insulin resistance markers like A1C and C-peptides. Learn how to interpret your results and what steps to take next.
Never miss a blog post.
